Aura Biosciences officer plans $119K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aura Biosciences, Inc. (AURA) officer Janet Jill Hopkins reported a planned sale of 16,903 common shares, with an approximate sale date of November 16, 2026 and an aggregate market value of $119,167. The sale is to occur automatically under the issuer’s mandatory, non-discretionary sell-to-cover arrangement to satisfy tax withholding obligations incurred upon vesting and settlement of equity awards. Morgan Stanley Smith Barney LLC is listed as broker; Amy Elazzouzi signed as attorney-in-fact.
Key Figures
Key Terms
sell-to-cover arrangement financial
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.